Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US AHRQ (Agency for Healthcare Research and Quality) study places drugs above surgery for GERD (gastroesophageal reflux disease) treatment

This article was originally published in Clinica

Executive Summary

In the first of a series of 10 studies comparing the effectiveness of medical treatments, researchers at the US Agency for Healthcare Research and Quality (AHRQ) have concluded that, in the treatment of gastroesophageal reflux disease (GERD), proton pump inhibitor drugs are as effective as surgery. The Medicare-mandated study - soon to be followed by studies on diabetes, breast imaging, depression and the off-label use of anti-psychotic drugs - took eight months in deciding that Nexium and Prilosec can be as effective at relieving symptoms as surgery.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT058221

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel